Cargando…
Sterilizing Activity of Fully Oral Intermittent Regimens against Mycobacterium Ulcerans Infection in Mice
BACKGROUND: The treatment of Buruli ulcer (BU) that is caused by Mycobacterium ulcerans, is currently based on a daily administration of rifampin and streptomycin (RIF-STR). A fully oral intermittent regimen would greatly simplify its treatment on the field. METHODOLOGY/PRINCIPAL FINDINGS: The objec...
Autores principales: | Chauffour, Aurélie, Robert, Jérôme, Veziris, Nicolas, Aubry, Alexandra, Jarlier, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5068736/ https://www.ncbi.nlm.nih.gov/pubmed/27755552 http://dx.doi.org/10.1371/journal.pntd.0005066 |
Ejemplares similares
-
Telacebec (Q203)-containing intermittent oral regimens sterilized mice infected with Mycobacterium ulcerans after only 16 doses
por: Chauffour, Aurélie, et al.
Publicado: (2020) -
Resistance of M. leprae to Quinolones: A Question of Relativity?
por: Veziris, Nicolas, et al.
Publicado: (2013) -
Sterilizing Activity of Second-Line Regimens Containing TMC207 in a Murine Model of Tuberculosis
por: Veziris, Nicolas, et al.
Publicado: (2011) -
New Insights into the Geographic Distribution of Mycobacterium leprae SNP Genotypes Determined for Isolates from Leprosy Cases Diagnosed in Metropolitan France and French Territories
por: Reibel, Florence, et al.
Publicado: (2015) -
Targeting the Mycobacterium ulcerans cytochrome bc(1):aa(3) for the treatment of Buruli ulcer
por: Scherr, Nicole, et al.
Publicado: (2018)